Should You Buy Pacific Biosciences of California (PACB)?
To the average investor, there are tons of metrics shareholders can use to analyze Mr. Market. A duo of the best are hedge fund and insider trading interest.
Chelsea Therapeutics International Ltd. (CHTP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Whitebox Advisors Andy Redleaf | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.32 | 4,900 | $6,467.51 | 450,178 | 2012-06-05 | Filing | |
| $1.32 | 100 | $132.00 | 445,278 | 2012-06-05 | Filing | |
| $1.31 | 8,000 | $10,480.00 | 11,000 | 2012-06-04 | Filing | |
| $4.50 | 4,000 | $18,007.60 | 8,305,049 | 2012-01-27 | Filing | |
| $4.46 | 13,900 | $61,994.00 | 8,301,049 | 2012-01-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.92 | 439,308 | $402,054.68 | 6,432,673 | 2012-12-17 | Filing | |
| $0.95 | 249,249 | $236,811.47 | 6,871,981 | 2012-12-14 | Filing | |
| $0.92 | 439,308 | $402,054.68 | 6,432,673 | 2012-12-17 | Filing | |
| $0.95 | 249,249 | $236,811.47 | 6,871,981 | 2012-12-14 | Filing | |
| $1.05 | 399,414 | $419,384.70 | 7,121,230 | 2012-12-12 | Filing |
News See All
Is Pacific Biosciences of California (PACB) Going to Burn These Hedge Funds?
Pacific Biosciences of California (NASDAQ:PACB) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Geron Corporation (GERN): Are Hedge Funds Right About This Stock?
To most investors, hedge funds are assumed to be worthless, old investment tools of the past.
Avoid This Biotech Stock: Chelsea Therapeutics International Ltd. (CHTP)
Editor's note: This article is a stock pitch made by a member on CAPS, The Motley Fool's free investing community.
This Week in Biotech: VIVUS, Inc. (VVUS), Roche Holdings Ltd-Spons Adr (RHHBY)
With the SPDR S&P Biotech Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Billionaire Hedge Funds
